Stereotactic radiosurgery recommended for patients with more than...

MD Anderson's fifth annual Boot Walk to End Cancer® goes...
Focus Fund and MD Anderson launch investment fund to...
MD Anderson, UT Austin Announce First...
Cancer remains one of the leading causes of death worldwide. While advances in cancer diagnoses and treatments are promising, more is needed to address this devastating disease.
Earlier this year, The University of Texas MD Anderson Cancer Center, UT Austin Oden Institute for Computational Engineering and Sciences, and UT Austin Texas Advanced Computing Center (TACC) launched a new collaboration in Oncological Data and Computational...
MD Anderson and Allogene Therapeutics announce strategic...
MD Anderson earns fifth Magnet designation for nursing...
Dual checkpoint blockade promising as pre-surgical approach...
Study identifies characteristics of infused CAR T cells...
Researchers at The University of Texas MD Anderson Cancer Center have identified molecular and cellular characteristics of anti-CD19...